Liu, Mingyue

Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues

Bailey, C. M., Liu, Y., Liu, M., Du, X., Devenport, M., Zheng, P., Liu, Y., & Wang, Y. (2022) · Journal of Clinical Investigation

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 151

Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice

Du, X., Liu, M., Su, J., Zhang, P., Tang, F., Ye, P., Devenport, M., Wang, X., Zhang, Y., Liu, Y., et al. (2018) · Cell Research

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 123

Surface modification of zirconia with polydopamine to enhance fibroblast response and decrease bacterial activity in vitro : A potential technique for soft tissue engineering applications

Liu, M., Zhou, J., Yang, Y., Zheng, M., Yang, J., & Tan, J. (2015) · Colloids and Surfaces B: Biointerfaces

Dental Implant Techniques and OutcomesPolymer Surface Interaction Studies

Cited by 113

Clinical features and risk factors for blood stream infections of Candida in neonates

LIU, M., HUANG, S., GUO, L., LI, H., WANG, F., ZHANG, Q., & SONG, G. (2015) · Experimental and Therapeutic Medicine

Antifungal resistance and susceptibilityNeonatal and Maternal Infections

Cited by 23